‘Real world evidence’ put to the test
JOE RAEDLE/GETTY IMAGES
Millions of people take amphetamine medicines such as Adderall or Vyvanes to tame their ADHD. A fraction of them — 1 in 660, according to a new study in the New England Journal of Medicine — have a psychotic event.
That’s the headline, but the way researchers arrived at the conclusion is also newsworthy, STAT’s Matthew Herper reports. The researchers gathered “real-world evidence” from medical practices, not the gold-standard of randomized, controlled clinical trials, to arrive at their conclusions. They worked with Aetion, a New York City health data startup. Another New York startup, Flatiron Health, was acquired last year by Roche — for $1.9 billion — for its business mining patient electronic medical records to replace more traditional clinical trial data. Flatiron is collaborating with the FDA, so real-world evidence is looking real.
Read more.
That’s the headline, but the way researchers arrived at the conclusion is also newsworthy, STAT’s Matthew Herper reports. The researchers gathered “real-world evidence” from medical practices, not the gold-standard of randomized, controlled clinical trials, to arrive at their conclusions. They worked with Aetion, a New York City health data startup. Another New York startup, Flatiron Health, was acquired last year by Roche — for $1.9 billion — for its business mining patient electronic medical records to replace more traditional clinical trial data. Flatiron is collaborating with the FDA, so real-world evidence is looking real.
Read more.
No hay comentarios:
Publicar un comentario